What Makes Prime Medicine, Inc. (PRME) a New Buy Stock
Yahoo FinanceMay 3 12:00 ET
Why Aspen Aerogels Shares Are Trading Higher By 26%; Here Are 20 Stocks Moving Premarket
Shares of Aspen Aerogels, Inc. (NYSE:ASPN) rose sharply in today's pre-market trading after the company reported better-than-expected first-quarter financial results.Aspen Aerogels posted a GAAP loss
BenzingaMay 2 05:43 ET
Prime Medicine to Participate in the 27th Annual Milken Institute Global Conference
PDF Version CAMBRIDGE, Mass., May 01, 2024 (GLOBE NEWSWIRE) -- Prime Medicine, Inc. (Nasdaq: PRME), a biotechnology company committed to delivering a new class of differentiated one-time curati
Prime MedicineMay 1 00:00 ET
FDA Clears Prime Medicine to Begin Gene Therapy Clinical Testing
Seeking AlphaApr 29 16:11 ET
Prime Medicine Shares Rise 13% After FDA Clears IND Application
By Chris Wack Prime Medicine shares were up 13%, to $5, after the company said that the U.S. Food and Drug Administration has cleared its Investigational New Drug application for PM359 for the treatm
WSJApr 29 13:29 ET
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Clever Leaves Holdings Inc. (NASDAQ:CLVR) fell sharply during Monday's session after the company announced that it will voluntarily delist its common shares from the Nasdaq and deregister it
BenzingaApr 29 13:04 ET
Tesla, Deciphera Pharmaceuticals, Heartland Financial And Other Big Stocks Moving Higher On Monday
U.S. stocks were higher, with the Nasdaq Composite jumping over 50 points on Monday.Shares of Tesla, Inc. (NASDAQ:TSLA) rose sharply during Monday's session on reports the company will partner with Ba
BenzingaApr 29 10:47 ET
Prime Medicine Shares Jump After Application for Chronic Granulomatous Disease Treatment Gets FDA Clearance
Prime Medicine (PRME) shares rose 8.5% in recent trading after the company said Monday that its investigational new drug application for potential treatment of chronic granulomatous disease received c
MT NewswiresApr 29 10:12 ET
Express News | Prime Medicine Shares Are Trading Higher on FDA Clearance of Its IND Application for PM359
BenzingaApr 29 07:14 ET
Express News | Prime Medicine Announces FDA Clearance of Investigational New Drug (Ind) Application for Pm359 for the Treatment of Chronic Granulomatous Disease (Cgd)
ReutersApr 29 07:00 ET
Prime Medicine Announces FDA Clearance of Investigational New Drug (IND) Application for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)
PDF Version First-Ever Open IND for Prime Editing TechnologyPM359 is Prime Medicine's Ex Vivo Product Candidate Designed to Correct a Prevalent Disease-Causing Mutation of CGDInitial Data Expecte
Prime MedicineApr 29 00:00 ET
12 Health Care Stocks Moving In Friday's After-Market Session
GainersBluejay Diagnostics (NASDAQ:BJDX) shares increased by 11.0% to $0.73 during Friday's after-market session. The company's market cap stands at $1.9 million. China Pharma Holdings, Inc. Common St
BenzingaApr 26 16:31 ET
Buy Rating Affirmed for Prime Medicine, Inc. on Strong Preclinical Data and Promising Clinical Outlook
TipRanksApr 25 12:35 ET
Express News | Wedbush Reiterates Outperform on Prime Medicine, Maintains $12 Price Target
Moomoo 24/7Apr 23 13:14 ET
Express News | Prime Medicine Shares Are Trading Higher After the Company Announced That It Will Present Preclinical Data Highlighting the Broad Potential of Its Prime Editing Technology and Supporting the Advancement of Its Programs at Upcoming Scientific Meetings
Moomoo 24/7Apr 23 10:54 ET
Prime Medicine to Present Preclinical Data Demonstrating Broad Potential of Prime Editing Technology at Upcoming Scientific Meetings
PDF Version -- Presentations include new preclinical data for PM359, further demonstrating ability of Prime Editors to efficiently, reproducibly and durably correct causative mutation of CGD; on
Prime MedicineApr 23 00:00 ET
Prime Medicine Initiated at Buy by Chardan Capital
Prime Medicine Initiated at Buy by Chardan Capital
Dow JonesApr 22 08:00 ET
Buy Rating Affirmed for Prime Medicine, Inc. on Groundbreaking Genetic Editing Platform and Strategic Progress
TipRanksApr 22 07:55 ET
Express News | Prime Medicine Inc : Chardan Capital Markets Initiates Coverage With Buy Rating; Target Price $17
Moomoo 24/7Apr 22 07:49 ET
Analysts Offer Insights on Healthcare Companies: Prime Medicine, Inc. (PRME), Arvinas Holding Company (ARVN) and Viridian Therapeutics (VRDN)
TipRanksApr 12 07:10 ET
No Data
No Data